The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

Acta Dermatovenerologica Croatica is a premier journal dedicated to the fields of dermatology and venereology, published by the Croatian Dermatovenereological Society. Established in 1994, this journal has been a vital platform for disseminating research and advancements in the understanding and treatment of skin diseases and sexually transmitted infections. Although it is currently classified in the Q4 quartile for dermatology, infectious diseases, and miscellaneous medicine, it provides a unique opportunity for emerging researchers and seasoned professionals to contribute to a growing body of knowledge. Based in Zagreb, Croatia, the journal emphasizes free access to information that enhances clinical practices and scientific understanding among dermatologists and venereologists worldwide. As the journal approaches its 30th anniversary, it continues to aim for excellence in research quality, fostering collaboration, and innovating in the ever-evolving fields it represents.

JOURNAL OF INVESTIGATIVE DERMATOLOGY, published by Elsevier Science Inc, stands at the forefront of research in the fields of dermatology, biochemistry, cell biology, and molecular biology. With an impressive impact factor reflecting its Q1 ranking in Dermatology and Biochemistry, this journal provides a vital platform for disseminating groundbreaking research and innovative studies that drive forward our understanding of skin biology and disease. The journal has maintained a distinguished presence since its inception in 1945, successfully converging decades of scientific inquiry and expertise. It ranks among the top journals in medicine and dermatology, holding a remarkable 7th place out of 142 in the Scopus Medicine Dermatology category, signaling its influence and relevance in the academic community. Researchers, professionals, and students alike will find valuable insights into cutting-edge investigations and methodologies to advance their own studies in skin health and pathology. While the journal is not an open access publication, access options remain robust for institutions and individuals committed to the advancement of dermatological science.

ANAIS BRASILEIROS DE DERMATOLOGIA is a prestigious academic journal published by Elsevier Science Inc, specializing in the dynamic field of dermatology. With its Open Access model established in 2002, this journal ensures wide dissemination of research findings and facilitates collaboration within the dermatological community. Hailing from Brazil, it provides a platform for innovative research from both local and international contributors, spanning from its inception in 1963 to the current year, 2024. The journal positions itself as a vital resource in the dermatology sphere, currently ranked in the Q3 category for dermatology and holding a notable rank of 71 out of 142 in the Scopus rankings, placing it in the 50th percentile for its field. With a commitment to advancing knowledge and practice in dermatology, ANAIS BRASILEIROS DE DERMATOLOGIA is an essential read for researchers, professionals, and students eager to explore contemporary advancements and clinical practices.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, published by Wiley, is a prominent periodical in the field of dermatology, recognized by its Q2 quartile ranking in the 2023 dermatology category. With a dedicated focus on advancing knowledge in dermatological science, the journal publishes rigorous peer-reviewed research that encompasses a range of topics including clinical studies, research methodologies, and innovative treatment practices in dermatology. Its impact is reflected in its Scopus ranking, where it stands at #48 out of 142 in the medicine dermatology category, placing it in the top 66th percentile. Although not an Open Access journal, it serves as a critical resource for researchers, clinicians, and students alike, facilitating the dissemination of high-quality research findings and fostering a deeper understanding of dermatological conditions and treatments. With years of convergence from 2003 to 2024, this journal remains a vital platform for scholarly dialogue and discovery in dermatology.

Australasian Journal of Dermatology is a leading publication in the field of dermatology, issued by Wiley since 1951, and reaching an audience of researchers, clinicians, and students interested in the latest advancements and practices in skin health. With an ISSN of 0004-8380 and an E-ISSN of 1440-0960, this journal stands out with its Q2 ranking in both Dermatology and Miscellaneous Medicine, positioning it within the top 61st percentile of its category according to Scopus. Although it does not provide Open Access options, Australasian Journal of Dermatology is committed to disseminating high-quality research that informs clinical practices and promotes scholarly dialogue. By publishing rigorous and peer-reviewed articles focused on various aspects of dermatological science, the journal plays a pivotal role in enhancing the dermatology community's understanding of skin conditions and treatments, making it an invaluable resource for professionals and students alike.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Turkderm - Turkish Archives of Dermatology and Venerology, published by GALENOS PUBL HOUSE, serves as a vital platform for the dissemination of innovative research and advancements in the fields of dermatology and venerology. With an Open Access policy implemented since 2002, this journal aims to provide free and unrestricted access to significant findings, ensuring that vital information reaches a global audience. Based in Turkey, the journal has positioned itself as an important resource for professionals, researchers, and students alike, despite currently being categorized in Q4 of both Dermatology and Infectious Diseases as per the 2023 metrics. Although it faces competition in the rankings, with a Scopus standing of #131 in Dermatology and #331 in Infectious Diseases, its dedication to advancing knowledge in these critical health areas is unwavering. The journal continually invites original research, reviews, and case studies that enhance clinical practices and foster understanding in the dermatological community.

The Journal of Skin Cancer, published by HINDAWI LTD, serves as a vital platform for advancing knowledge in the fields of Dermatology and Oncology. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, making significant contributions to the understanding of skin cancer pathogenesis, diagnosis, and treatment strategies. The journal holds a respectable rank within the academic community, reflected in its Q3 category placement in both Dermatology and Oncology for 2023, as well as its Scopus rankings, which place it in the 49th and 34th percentiles, respectively. Targeting an audience that includes researchers, healthcare professionals, and students, the Journal of Skin Cancer not only aims to present original research but also solicits reviews and case studies, thereby fostering a rich academic dialogue. With its headquarters located in London, England, the journal encourages global engagement and collaboration among scholars committed to improving outcomes in skin cancer.